C-WDDPEtheros Pharmaceuticals
enzyme mimetics, neuroprotection, healthspan
modulatingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-WDDP
C-WDDPC-WDDPenzyme mimetics, neuroprotection, healthspan
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Etheros Pharmaceuticals enzyme mimetics, neuroprotection, healthspan
Etheros is pioneering small molecule drugs that mimic endogenous enzymes including superoxide dismutase and catalase. The site states these enzymes prevent oxidative and inflammatory injury, especially in neural tissue. Its lead compound is described as neuroprotective in double-blind, placebo-controlled animal studies and as extending median lifespan in wild-type mice by around 15% when dosed from middle age.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Etheros Pharmaceuticals — Early mechanism · Bottom quartile. Derived deterministically from 2 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Modifiers: +5 depth (2 programs at preclinical).…
Source: Deterministic